< back to news
New Oncology Non-proprietary LC/MS/MS Method Offered by Advion
June 19, 2007– The recent surge in oncology research within the pharmaceutical industry has produced a variety of oncology drugs for the treatment of a number of cancers. Treatments typically include a cocktail of prescriptions, so it is vitally important to understand the effects of co-administered drugs. Advion has a comprehensive list of validated oncology non-proprietary methods. Advion has recently added paclitaxel, its metabolite 6-hydroxypaclitaxel and gemcitabine to its offering of validated non-proprietary methods.
Advion offers a comprehensive list of validated oncology non-proprietary methods:
Bortezomib
5-Fluorouracil
Gemcitabine
Imatinib, N-desmethyl Imatinib
Paclitaxel, 6-hydroxypaclitaxel
A full list of Advion's validated non-proprietary
methods to support drug-drug interactions or comparison studies is available
on its website. |
